Tenon Medical Inc (TNON)
0.87
+0.03
(+3.57%)
USD |
NASDAQ |
May 07, 16:00
0.87
0.00 (0.00%)
After-Hours: 20:00
Tenon Medical Research and Development Expense (Quarterly): 0.691M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.691M |
September 30, 2023 | 0.737M |
June 30, 2023 | 0.901M |
March 31, 2023 | 0.834M |
December 31, 2022 | 0.812M |
September 30, 2022 | 0.797M |
Date | Value |
---|---|
June 30, 2022 | 0.657M |
March 31, 2022 | 0.562M |
December 31, 2021 | 0.793M |
September 30, 2021 | 0.601M |
June 30, 2021 | 0.237M |
March 31, 2021 | 0.087M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.087M
Minimum
Mar 2021
0.901M
Maximum
Jun 2023
0.6424M
Average
0.714M
Median
Research and Development Expense (Quarterly) Benchmarks
QuidelOrtho Corp | 59.30M |
Perspective Therapeutics Inc | 6.08M |
Xtant Medical Holdings Inc | 0.492M |
Asensus Surgical Inc | 8.614M |
Catheter Precision Inc | -0.011M |